These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31743032)

  • 1. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
    Stewart AM; Grass ME
    Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.
    Stewart AM; Grass ME; Brodeur TJ; Goodwin AK; Morgen MM; Friesen DT; Vodak DT
    Mol Pharm; 2017 Jul; 14(7):2437-2449. PubMed ID: 28591516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs.
    Kesisoglou F; Wang M; Galipeau K; Harmon P; Okoh G; Xu W
    J Pharm Sci; 2019 Sep; 108(9):2917-2925. PubMed ID: 30980857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
    Fine-Shamir N; Dahan A
    Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport.
    Wilson V; Lou X; Osterling DJ; Stolarik DF; Jenkins G; Gao W; Zhang GGZ; Taylor LS
    J Control Release; 2018 Dec; 292():172-182. PubMed ID: 30408553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
    Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
    Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: Sporanox® pellets.
    Dietrich S; Dimoula M; Argyropoulos T; Ceulemans J; Goumas K; Vertzoni M; Reppas C
    Eur J Pharm Sci; 2024 Aug; 199():106798. PubMed ID: 38740075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
    Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
    Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agents.
    Hilgers AR; Smith DP; Biermacher JJ; Day JS; Jensen JL; Sims SM; Adams WJ; Friis JM; Palandra J; Hosley JD; Shobe EM; Burton PS
    Pharm Res; 2003 Aug; 20(8):1149-55. PubMed ID: 12948011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.
    Miller JM; Beig A; Krieg BJ; Carr RA; Borchardt TB; Amidon GE; Amidon GL; Dahan A
    Mol Pharm; 2011 Oct; 8(5):1848-56. PubMed ID: 21800883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.